Journey Medical Corp Files 8-K
Ticker: DERM · Form: 8-K · Filed: Jul 14, 2025 · CIK: 1867066
Sentiment: neutral
Topics: regulatory-filing, 8-k
TL;DR
JRNMD filed an 8-K, but no juicy details yet.
AI Summary
On July 14, 2025, Journey Medical Corporation filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," with no specific material events or financial details disclosed in the provided text. The report confirms Journey Medical Corporation's status as a Delaware-incorporated entity with its principal executive offices in Scottsdale, Arizona.
Why It Matters
This filing indicates Journey Medical Corporation is meeting its regulatory reporting obligations. However, the provided excerpt does not contain specific business or financial updates.
Risk Assessment
Risk Level: low — The filing is a routine procedural document without disclosed material events, thus posing minimal immediate risk.
Key Players & Entities
- Journey Medical Corporation (company) — Registrant
- Delaware (jurisdiction) — State of Incorporation
- Scottsdale, AZ (location) — Principal Executive Offices
FAQ
What is the purpose of this 8-K filing for Journey Medical Corporation?
The filing is a Current Report on Form 8-K, primarily covering "Other Events" and "Financial Statements and Exhibits" as of July 14, 2025.
When was this 8-K filed by Journey Medical Corporation?
The report was filed on July 14, 2025.
Where are Journey Medical Corporation's principal executive offices located?
The principal executive offices are located at 9237 E Via de Ventura Blvd., Suite 105, Scottsdale, AZ 85258.
Under which section of the Securities Exchange Act is this report filed?
The report is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
What is Journey Medical Corporation's state of incorporation?
Journey Medical Corporation is incorporated in Delaware.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 14, 2025 regarding Journey Medical Corp (DERM).